Abstract: Optimal treatment for patients with chronic pain remains elusive. A growing international consensus advocates evidence-based practice with assessment of clinical outcomes to improve the process and outcome of care. Clinical decision making about treatment options for an individual patient should include the patient's clinical presentation, available evidence, and patient preferences. Treatment should then be monitored and outcomes of treatment assessed. Although the placement of clinical decision making on a scientific, often quantitative basis as opposed to a subjective, impressionistic approach makes intuitive sense, the question is whether we have been measuring what we need to measure to practice evidencebased practice when we consider the current available evidence on pain management? The methods of synthesis of available evidence are still in development. Much of the evidence, although having internal validity, has limited external validity and is difficult to apply to the individual patient. Patients with chronic pain are a heterogeneous group, and different interventions may be indicated for different subgroups of patients. Various methods are being developed to better match patients with treatment. Little information exists on patient preferences, or how best to measure these. Information on how health care providers make clinical decisions is also scarce. Outcome measurement has come a long way and core domains to be measured have been established. Establishing normative data is a next main goal. Important methodologic and practical challenges remain to formulate evidence that can be applied to the individual patient with chronic pain.
Abstract: Optimal treatment for patients with chronic pain remains elusive. A growing international consensus advocates evidence-based practice with assessment of clinical outcomes to improve the process and outcome of care. Clinical decision making about treatment options for an individual patient should include the patient's clinical presentation, available evidence, and patient preferences. Treatment should then be monitored and outcomes of treatment assessed. Although the placement of clinical decision making on a scientific, often quantitative basis as opposed to a subjective, impressionistic approach makes intuitive sense, the question is whether we have been measuring what we need to measure to practice evidencebased practice when we consider the current available evidence on pain management? The methods of synthesis of available evidence are still in development. Much of the evidence, although having internal validity, has limited external validity and is difficult to apply to the individual patient. Patients with chronic pain are a heterogeneous group, and different interventions may be indicated for different subgroups of patients. Various methods are being developed to better match patients with treatment. Little information exists on patient preferences, or how best to measure these. Information on how health care providers make clinical decisions is also scarce. Outcome measurement has come a long way and core domains to be measured have been established. Establishing normative data is a next main goal. Important methodologic and practical challenges remain to formulate evidence that can be applied to the individual patient with chronic pain.
Key Words: evidence-based practice, chronic pain, patient preferences, outcome assessment (Clin J Pain 2008;24:316-324) P roviders must work in partnership with patients to achieve outcomes that reflect patient preferences and cultural mores, provide value for money, and obtain sufficient information to implement and guide treatment. The difficulties that beset all health care providers who wish to deliver both quality and cost-effective care are particularly challenging where pain is concerned. A growing international consensus advocates evidencebased practice (EBP) with assessment of clinical outcomes to improve the process and outcome of care. 1 The methods of EBP help practitioners organize and use the best available evidence already at hand. EBP is formally defined as ''The conscientious, explicit and judicious use of current best evidence in making decisions about the care of individual patients. The practice of EBP means integrating individual clinical expertise with the best available external clinical evidence from systematic research.'' 2 (p 246) EBP thus is an integration of 3 important components: the best clinical research evidence, clinical expertise, and patient values or preferences for alternative forms of care. The final step of EBP is to evaluate performance, in other words, measure whether the treatment achieved the desired results. The principal attraction of EBP is its placement of clinical decision making on a scientific, often quantitative basis as opposed to a subjective, impressionistic approach. 3 In recent years, much emphasis has been placed on ''finding and critically appraising the evidence'' seemingly to the exclusion of the other components of EBP; a development that has EBP proponents worried. The EBP model was therefore recently revised to state that clinical decisions must include consideration of, first, the patient's clinical and physical circumstances to establish what is wrong and what treatment options are available. Second, the latter need to be tempered by research evidence concerning the efficacy, effectiveness, and efficiency of the options. Third, given the likely consequences associated with each option, the clinician must consider the patient's preferences and likely actions (in terms of what interventions she or he is ready and able to accept). Clinical expertise is needed to bring these considerations together and recommend the treatment that the patient is agreeable to accepting. 4 Finally, the outcomes of care should be measured to determine if the chosen intervention was effective.
Although the purpose of EBP is to make the best treatment decisions for individual health outcomes, evidence for patients with chronic pain is often lacking. Even when evidence exists in the form of systematic reviews or meta-analyses, results may not be applicable to the individual patient, because patients with chronic pain rarely have 1-dimensional problems. Each patient has a complex array of characteristics, and individuals differ in their responses to many interventions. Just as it may be invalid to generalize from small-scale observations to large groups, one can never say with certainty that an aggregate conclusion drawn from a large group applies well to each subgroup 5 or individual. [6] [7] [8] [9] The question we sought to debate is, considering the above model, do we have enough information to practice Best Practice?
EVIDENCE FROM CLINICAL CARE RESEARCH
When faced with a clinical treatment question, we find meta-analyses and systematic reviews at the top of the research evidence pyramid. The young fields of literature synthesis and systematic reviews 10 are still in flux, and many cautionary notes have been struck regarding the potential for uncritical misapplication of such methods. 11, 12 Issues related to grading the quality of individual articles employed as the elements of analysis in evidence-based reports and systematic reviews are complex 10 and the methodology for both the assessment of quality and its incorporation into systematic reviews and meta-analysis are a matter of ongoing debate. 13 Furthermore, investigators committed to qualitative research or observational studies argue with merit that meta-analysis is not feasible for many medical decisions 12,14 -a position that stalwarts of EBP themselves support. 5, 6, 8, 9, 15, 16 The hierarchy of research design is currently under debate because few studies have actually attempted to obtain empirical verification of the inherent superiority of randomized trials over nonrandomized trials. Some find that the results of well-designed observational studies (with either a cohort or a case-control design) do not systematically overestimate the magnitude of the effects of treatment as compared with those in randomized, controlled trials on the same topic, [17] [18] [19] [20] although others disagree. 21 As a group, in comparison with clinical trials in other areas of therapy, randomized controlled trials (RCTs) related to pain tend to be of low quality owing to the small numbers of patients enrolled; flaws in patient randomization, assignment, and retention; scanty descriptions of the patients enrolled; and heterogeneity in the methods and timing of assessment of pain and other outcomes. 22 Many interventions in pain control RCTs are sparse and too disparate to consolidate. 23 Thus, for much of clinical practice there is no ''best evidence.'' Methodologically sound RCTs avoid the chaos of daily clinical practice by eliminating cointerventions, patients most likely to be lost to follow-up, comorbidities and strong treatment preferences, by including standardized treatment irrespective of individual patients' clinical signs and symptoms and comparing with sham interventions. Although this ensures a high degree of internal validity, it considerably reduces external validity, or generalizability to ''real world practice.'' If systematic reviews value methods where interventions are not representative of ''real world care,'' then most clinicians are not going to blindly follow the recommendations of those reviews. 24 Appraisal of the methodologic quality of primary studies is essential in systematic reviews, but no consensus exists on the ideal checklist and scale for assessing methodologic quality. 25 To date more than 25 quality scales have been developed. The scales vary widely in the dimensions they cover, their size, and complexity and the weight assigned to the key domains most relevant to control of bias varies widely among them. 26 It has been shown that the choice of the scale influences the weight of individual studies in the analysis and that the combined effect estimate and its confidence interval therefore depend on the scale. 27 Nonpharmacologic treatment has specific methodologic issues, such as it often being technically or ethically difficult to perform a sham intervention; the difficulty of blinding of patients and care providers; the success of the treatment depending on the care providers' clinical competence and enthusiasm; the patients' preference for and compliance with treatment. Optimal dosage, such as the frequency and intensity, of the intervention is often unknown. Finally, nonpharmacologic treatment is usually complex and difficult to standardize, and technical modification (treatment adjustment) may occur as the intervention evolves. 28 None of the quality scales take these issues into account, raising the question whether they should be used to rate the quality of nonpharmacologic studies.
When a meta-analysis is impossible owing to heterogeneity of study populations, interventions, and outcome, rating systems are used to indicate the strength of evidence. Hierarchies of evidence can lead to anomalous ranking because of the objective of collapsing the multiple dimensions of quality into a single grade. Some dimensions are more important for some clinical problems and outcomes than for others, which necessitates a tailored approach to appraising evidence. 29 The potential for different conclusions when different sets of levels of evidence criteria are applied to the same data set is illustrated by the data on back schools. Heymans et al 30 conclude that ''there is moderate evidence that back schools provide better short-term effects than other treatments for chronic low back pain'' (p 8). In contrast, 3 other sets of levels of evidence criteria produced 3 different conclusions on the efficacy of back school: weak evidence, limited evidence, and no evidence. 31 Six prominent systems were recently critically appraised by a group of experts. Their conclusion was that all of the currently used approaches to grading systems of evidence and the strength of recommendations have important shortcomings. 32 Although there is evidence that the available ''evidence'' needs to be interpreted with caution, metaanalyses and systematic reviews have often yielded effect sizes that are too small to warrant much enthusiasm. 33, 34 Possible explanations for these results is the tendency to treat chronic pain patients as a homogeneous group with generic treatments, using inappropriate research designs and using outcome measures that are insufficiently sensitive to change. An alternative explanation could be that pain treatment does not actually make much of a difference.
Turk 35 was the first to propose a greater conceptualization of patients with chronic pain with a multiaxial classification system that goes beyond the medical diagnosis and has been fighting adherence to ''patient and treatment uniformity myths'' for almost 2 decades. Patients with chronic pain are not a homogeneous group and different interventions may be indicated for different subgroups of patients. 36 Matching treatment to patient characteristics has been shown to improve outcomes of clinical care. 37 Vlaeyen and Morley 34 introduced the aptitude Â treatment interaction (ATI) model to better match cognitive behavioral treatments to patient characteristics.
The results of prognostic studies give evidence for a better utilization of resources by performing an easy screening of the patients before treatment, and allocating the patients to adequate treatment. 38 These clinical prediction rules (CPR) may help define subgroups that respond to specific treatment. A CPR can be defined as a clinical tool that quantifies the individual contributions that various components of the history, physical examination, and basic laboratory results make toward the diagnosis, prognosis, or likely response to treatment in an individual patient. 39 For instance, evidence exists that the response to manipulation in acute low back pain may increase from 43% to 95% when a CPR is followed. 40 In a randomized controlled study by Haldorsen et al, 41 654 patients, who were long-term sick listed because of musculoskeletal pain, were divided into good, medium, or poor prognosis by using a standardized psychologicphysiotherapeutic screening instrument. The results of this study showed that choice of treatment (ordinary treatment, light multidisciplinary, or extensive multidisciplinary treatment) was especially important for patients classified to have poor prognosis for return to work.Extensive multidisciplinary treatment for these patients seemed to be superior both from the patient's point of view and from an economic perspective. 38 A number of studies have found that high initial pain is a predictor of poor recovery in patients with whiplashassociated disorders, [42] [43] [44] suggesting early treatment to targeted risk groups may prevent chronicity. This is underscored by Linton and Hallden, 45 who developed a screening questionnaire predicting chronicity in patients with acute and subacute low back pain. Using this questionnaire, subgroups were identified that were clearly related to outcome. 46, 47 Defining subgroups is the first step; matching treatment is the next. But what research design to use? The pragmatic RCT aims to bridge the gap between the limited external validity of the RCT and the limited internal validity of observational studies. 48 Pragmatic RCTs reflect the heterogeneity of patients, minimize exclusion criteria, define patients by presentation, rather than diagnosis, may not employ placebos, may not be blinded and must carefully conceal allocation during randomization. 48, 49 Although this research design has no official place (yet) in the research evidence pyramid, the results of these studies may yield more evidence that we can apply to our individual patients than is currently the case. Ultimately improvement in clinical care and patients' outcomes will come from conducting the right kind of research, research that is of importance in the real world, that will help us to treat the right patients with the right treatment at the right time. 38, 50 
WHAT WORKS FOR WHOM: PREDICTION RULES VERSUS CLINICAL EXPERTISE?
How can we help to find the right treatment for each individual with chronic pain? The implementation of results from scientific studies in patient care is not as straightforward as it seems. For example, although in a diversity of scientific studies, different treatment options in nonspecific pain syndromes are evaluated, in clinical practice no nonspecific pain patient will visit your consultation-hour. Each person has his/her own spectrum of clinical, physical, and psychosocial circumstances that taken together may explain the disability level in pain. To be able to determine the optimal treatment for each individual, as much as possible a thorough inventory of all likely contributing factors that could influence a patient's disability level due to pain is important. Such an initial evaluation will therefore necessarily contain medical, physical, and psychosocial components.
In the management of chronic pain, as in general medicine, an important initial step in clinical decision making is the detection of an underlying medical diagnosis, which can explain a patient's complaints. On the basis of a diagnostic triage, consisting of a combination of a history, a physical examination, and a set of additional diagnostic tests when indicated (such as a x-ray, magnetic resonance image, etc), clinical circumstances of patients will be identified. For individuals with pain, however, these basic principles of clinical practice will result in the detection of an underlying medical disease only a minority of cases. For only 15% of patients with low back pain, a specific medical diagnosis can be made. 51 For the majority, no medical diagnosis explaining their level of disability can be found. In case a medical underlying diagnosis could be made, there often still is a discrepancy between these clinical findings and the presented level of disability. Despite the absence of an adequate medical ''label,'' these patients also perceive limitations in the performance of activities of daily life. Especially if clinical circumstances cannot be classified into a medical diagnosis, it is important to identify physical circumstances of a patient. The focus of clinical decision making changes therefore from setting a medical diagnosis to the assessment of the impact of the syndrome on daily life functioning. In addition, a second diagnostic goal is the identification of behavioral factors that could explain the manner in which a patient deals with his pain and his or her impaired level of functioning. In several studies, behavioral factors (fear, fear-avoidance, and anxiety) have been found to both predict and explain chronic pain disability. [52] [53] [54] These behavioral factors can, in the absence of a clear medical diagnosis, serve as a goal for treatment to decrease the impact of pain on daily functioning. For example, if the level of fear for injury can be decreased, a patient's disability level can be reduced, even without a change in the level of pain intensity.
Valid and reliable measurement of the level of disability, the level of physical activity in daily life, and interfering behavioral factors in patients with pain seems therefore important to characterize a patient's clinical state and circumstance to be able to choose the optimal treatment. As mentioned, assessment of behavioral factors in pain is important as a diagnostic tool for treatment. In addition to the (verbal) history taking, standardized questionnaires can be used to support the diagnosis. A number of standardized questionnaires have been developed to assess pain related fear [including the Tampa Scale for Kinesiophobia, 55 the Fear Avoidance Beliefs Questionnaire, 56 and anxiety Pain Anxiety Symptoms Scale (PASS) 57 ]. In addition, the concept of fearavoidance is often used in screening tools that identify which patient will develop long-term pain and disability. For instance, the Ö rebro Musculoskelal Pain Screening Questionnaire is used as a tool for clinicians in the early identification of problem cases. 46 It has cutoff points for use in primary care settings, which provide a gross estimation of the probability of a patient being on sick benefits 6 months later. As an intervention for identified patients, early secondary prevention can be directed toward preventing pain disability evolving into a chronic pain syndrome. To match a patient to a treatment, prediction rules have been developed to predict treatment-outcome in cognitive behavioral treatment. In clinical psychology, the ATI was introduced to match the right cognitive behavioral treatment to the right patient. 37 Performing ATI research is not easy though, as measuring and interpreting interaction effects can be more complex than dealing with main effects. Moreover, it is essential to know exactly how the treatment works, which is often not the case in the multidimensional treatment for chronic pain. For research in chronic pain, Vlaeyen and Morley, 34 also proposed to conceptualize the question ''What works for whom?'' according to the moderator-mediator distinction of Baron and Kenny. 37 Using this distinction, dimensions of the treatment process have to be classified as mediator or moderator variables. A moderator provides an answer to the question ''in what circumstances does the association appear'' and a mediator will answer the question ''how does the association work.'' Both moderators and mediators can serve the process of matching the right patient to the right therapy. However, at this moment, research on evidence-based prediction rules in chronic pain has not resulted in a screenings instrument, which can be used in clinical practice to assist patient selection.
Does chronic pain result in a reduction of the level of physical activity in daily life? Information on both the construct of disability (limitations in performance) and physical activity (actual performed activities) seems important to collect, because both constructs can complement each other in objectifying a patients' daily performance. According to the International Classification of Functioning and Diseases (ICF), information on the level of physical activities in daily life is to be preferred over information on the level of disability. 58 In clinical practice, the identification of the level of physical activity is often a part of history taking, and consists of a verbal report of the patient on the level of physical activity. Self-report on physical functioning, however, can reflect a difference between how patients function and how they believe they function. This results in a different reported physical activity level compared to the actual observed active behavior. 59 In an experimental setting, it appeared that patients in pain had particular difficulties judging their own performance. 60 As a result of this, selfreport measures, such as questionnaires or diaries, which are easy to administer, require little time, and are inexpensive, have to be evaluated critically in patients with chronic pain. Important for all registrations of physical activity in daily life is the fact that registration in both healthy persons and patients with pain must reflect a mean activity level over more than 1 day to represent normal daily life. Gretebeck and Motoye 61 stated that all methods measuring physical activity in daily life need at least 5 or 6 days of registration to minimize intraindividual variance.
In rehabilitation practice, there is a tendency to use more objective measures to assess physical activity as compared with self-report. A variety of methods for measuring a patient's level of physical activity exist. Most assessment methods are derived from research in movement sciences. For example, physical activity in daily life can be assessed on the basis of observation, for instance by video recording, followed by an interpretation. Observational techniques are generally considered reliable, 62 but their administration is costly and timeconsuming and, therefore, probably only useful on a time-sample basis. Another possibility is the registration of physical activity in daily life with ambulatory systems using motion sensors. A variety of systems exist, ranging from pedometers, designed to count steps, to 3-dimensional activity monitors giving more specific data on postures and activities during movement. In chronic low back pain, research has been performed using accelerometry. 63 This technique makes it possible to measure changes in the quantity of activities and changes in the pattern of physical activities over days. A third possibility is the measurement of physiologic markers. A simple physiology-related method is a 24-hour heart rate registration. However, this registration can be biased as a reaction to stress andtends to be less accurate in low level physical activity. 64 As in chronic pain the level of physical activity is probably limited, and stress-related problems can be present, heart rate registration seems to be less ideal for measuring physical activity in chronic pain.
At this moment, prediction rules covering all components of the biopsychosocial model of disability in chronic pain are not available yet. As a result of that, valid and reliable assessments of clinical, physical, and psychosocial circumstances are all important to objectify a patient's situation to be able to choose the best individual treatment based on clinical expertise. Particularly so for patients, for whom an underlying medical disease could not be identified, a valid description of both the impact of pain on daily functioning and the additional role of behavioral factors explaining their disability level are important.
PREFERENCES, VALUES, AND CIRCUMSTANCES
The patient's role as a partner in clinical decision making is often not formalized and is sometimes overridden and ignored by health care providers. The provider, but also the patients' beliefs and attitudes, can obstruct effective pain management.
People's values refer to the unique preferences, concerns, and expectations they bring to a clinical encounter and which must be integrated into clinical decisions if they are to be effective. 2 People's values often emerge in the stories they share. People's stories emerge in relation to dramatic events such as pain, and their stories give meaning to the significance of the event in their lives. 65 This has been demonstrated in narrative research where the search for meaning has been of central importance for the people living with pain. [66] [67] [68] One of the challenges posed by pain is articulating a highly personal internal sensation so that others, such as health workers can connect with the experience. 66 Being believed within one's social context becomes a central task for people living with chronic pain and is attempted through words and gestures. 66, 69 When those living with pain are not ''heard,'' the consequence may be that people are prevented from dealing with the situation. Understanding and support from health workers and others are central for facilitating effective self-care of pain. This understanding can only come when the context of pain is shared. People with chronic pain desire health workers to go further than simply to focus on the symptoms and progression of disease, but to also incorporate the impact of the illness and the meaning within the person's life. Respect for the context of the person becomes central to the health practitioner-patient relationship. 66 Pain exists in human experience. To understand the pain experience, we must be open to understanding the context of people's lives in which pain is experienced. For the person in pain, there is no reality besides the pain they are experiencing. If it hurts, it is real. Chronic pain can be life altering, intruding upon physical and social capacity and changing people's perception of self. 66, 70 Conclusions from an extensive review of the empirical research in relation to chronic pain were that: despite the progress that has been made in recent years, there continue to be a large number of individuals who are not adequately treated, and show quality of life is adversely affected by the various conditions collectively referred to under the rubric ''chronic pain.'' It is now clear that the Cartesian mind-body dualism that has characterized earlier efforts to understand pain is no longer tenable, and will not advance our knowledge of pain.yChronic pain is a multidimensional problem that requires a multidimensional solution. 71 (p 36)
The ways that we as individuals respond to pain may be influenced by our past experiences, our values, and cultural factors. People with the same pathology may develop different meanings of pain and describe different experiences with pain. 72 In addition, the sensation of pain may be interpreted differently by people from different ethnic groups whose response are framed by meanings they have learned in their own families and communities. Cultural differences have been recognized in how people experience chronic pain and how people may receive care from health workers 73 and how culture impacts upon the relationship between providers and people with chronic pain. 74 People of various cultures may react differently toward pain experiences, and this behavior is often dictated by the culture that provides specific norms according to the age, sex, and social position of the individual. People from different cultures may assume differing attitudes toward different types of pain. Pain during childbirth may be one example. In some cultures, there are expectations to alleviate the pain associated with childbirth, where as in other cultures, pain during childbirth is accepted. Pain associated with illness or injury, however, may be less accepted. This understanding of cultural influences will emerge through qualitative inquiry.
It is important that we understand the culture and experiences of others, however, as health practitioners we also need to understand how our own upbringing effects our attitudes about pain. Our past personal experiences may lay a framework for the judgement of others. Health practitioner attitudes and preferences have been found to influence the chronic pain care provided to people. 67, 68 People who were considered by health practitioners as to be exaggerating pain-evoked frustration in workers, whereas people who were perceived as enduring their pain-evoked satisfaction. 68 We are likely to believe that our own reaction to pain is ''normal'' and that other reactions are ''abnormal.'' Thus a health practitioner from a stoic family may not know how to react to a person who responds to pain by loud verbal complaints. Even subtle cultural and individual differences, particularly in nonverbal, spoken, and written language, between health practitioners and people can impact care. 68, 74 To work effectively with people toward understanding and living well with pain, a broad range of knowledge and understanding must be synthesized. Routine application of standard outcome assessment tools can help improve communication and facilitate the detection of symptoms, documentation of their severity, and assessment of the effectiveness of treatment. 75 Qualitative inquiry offers possibilities for understanding the experience of pain. Unfortunately, the ability to combine research expertise across the traditional methodologic paradigms of qualitative and quantitative inquiry is often thwarted. Qualitative and quantitative researchers often operate with a different set of assumptions about the world and ways of learning about it. Researchers are often taught to work within only one type of method, and develop expertise in either quantitative or qualitative analysis, but not usually both. The result is that the 2 major approaches (qualitative and quantitative) are seldom combined and the respective strengths of the 2 methods are obscured.
Pain is a phenomenon that needs to be studied from a combination of perspectives, using both qualitative and quantitative methods. The effectiveness of health research about and on the experience of pain lies in the shared application of both qualitative and quantitative research perspectives, methods, and tools.
CLINICAL EXPERTISE
Clinical expertise is the proficiency and judgment individual clinicians acquire through clinical experience and clinical practice. 76 Good doctors use both clinical expertise and the best available external evidence. How then, do we explain the wide variability in pain management and the undertreatment of patients with pain documented in all forms of health care settings? Studies show that the treatments that patients receive often reflect what the practitioner remembers from formal training rather than on current best treatment. 77 Practice variability has been related to race, ethnicity, age, and sex of both the physician and patient. 78 The assessment and treatment of pain have repeatedly been found to be worse in minorities, the very young, the very old, and in women and people with HIV/AIDS. 79 Green et al 80 found no correlation between physicians' confidence in their knowledge and abilities to manage pain and their ability to make good treatment decisions. Attention has been directed at the knowledge and attitudes of health care providers with limited success. It seems that although the education of health care providers and patients is important, it is not enough. 81 
OUTCOMES ASSESSMENT
Evaluation of patients, whether it is at initial or outcome assessment, is generally agreed as a critical aspect of EBP. Typically, in the pain field most experts recommend that these evaluations should include a combination of some performance-based measures (eg, sitting or standing tolerances), and also external criterion variables (eg, return to work) and self-reported measures (of a range of variables, including pain qualities, mood, disability, pain-related beliefs, and coping strategies). 82, 83 That such evaluations should be multidimensional in nature seems widely accepted, as is the recognition that the measures employed should have adequate reliability and validity properties. Interestingly, recognition of the importance of relevant normative data is much less evident. More than a decade ago Turk and Melzack 84 made the observation that the interpretation of selfreported measures is impossible without normative data. Without information on questionnaire scores from a clinically relevant group of chronic pain patients, as a frame of reference, a particular score for an individual patient has little meaning. Lacking meaning, the clinical utility of a score must be limited. Although data on some measures with different pain samples are now available (eg, Multidimensional Pain Inventory 85 and the Chronic Pain Grade scale 86 ), there is little evidence that the repeated calls for normative data on commonly used measures has been widely heard. For example, in the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials recommendations on core outcome domains for chronic pain clinical trials 82 noted ''the next step would be to select measures that meet appropriate psychometric standards (ie, reliability, validity, responsiveness, appropriate, normative data)'' (p 338) (italics added).
In the same decade, there has been an extensive discourse in the field of clinical epidemiology on the interpretation of test results, including the use of normative data. However, many different views on the nature of norms have been expressed. For example, Sackett et al 87 identified 6 definitions of ''normal'' in common clinical use. Thus, the call for normative data for self-reported measures in chronic pain reflects, in part, a wider concern with how test data are used in clinical settings.
Typically, psychologists have used the term ''norm'' to represent the performance on a measure or test by a standardization sample. 88 A medical example may be seen in the assessment of blood pressure: by themselves, blood pressure readings are meaningless. But once we know the normal range for the healthy people in the relevant comparison sample, we can immediately interpret the readings. This is rarely the case in the pain field, despite repeated assertions that the ratings by a patient (or sample of patients) of their disability or distress are considered ''high'' or ''low.'' Ideally, an individual should be compared with a standardization sample that is as comparable as possible (eg, in terms of age, sex, pain site).
The utility of normative data for pain measures applies to the interpretation of research (evidence) findings and clinical contexts. With suitable norms, the clinicians would be greatly assisted in identifying RCTs that involved patients like those in their practice, providing they used at least some of the same evaluation measures (as those used in the studies). This would provide a guide as to which studies were relevant to the types of patients seen in the clinician's setting. As mentioned earlier, the medical diagnosis and pain site, by themselves, are often insufficient for characterizing groups of chronic pain patients. Knowing how the samples scored on commonly used, scales that had normative data for reference would provide a more accurate basis for comparison of samples. Unfortunately, at our current stage of knowledge such normative data remain elusive. There is clearly a challenge for pain researchers across the world to develop data collection methods to capture suitable data so norms for pain patients from different age groups, cultures, pain sites, etc, on a range of commonly agreed scales can be established to enhance our ability to make best use of available evidence. The Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials group has provided an example of the sorts of measures that might be used in this context. 82 
CONCLUSIONS
The science of medicine is to discover generalizable truths that are demonstrable not in individuals but in groups; but the patient and his illness are unique. 15 The potential for distraction by all the marvelous tools of EBP, should it result in a failure to keep patients and their families at the center of all our efforts, would be most unfortunate. 89 Evidence remains a tool for clinical decision making and should not dictate practice. Important methodologic and practical challenges remain to formulate evidence that can be applied to the individual patient. As (chronic) pain practitioners, we have an expanding range of treatment options available to us, few with convincing evidence of superior efficacy compared with alternative treatments. It is likely that even when the evidence is obtained, categorized, and summed up, a single answer will not be enough to guide practice. 5 We must simply evaluate each patient and use the limited evidence available to us at present to guide compassionate and rational, if not yet fully EB, use of therapy for our patients. 3 
